METHODS: Pooled data were analyzed from four randomized, double-blind, placebo-controlled studies that compared duloxetine at the dose range approved in Japan ( __number__ mg/day) with other SSRIs (paroxetine __number__ mg/day or escitalopram __number__ mg/day) and placebo in patients with major depressive disorder.